» Go to news main
"The Wave" reveals strengths and priorities for medical research
Dalhousie Medical School has announced its leading research teams and strategic research priorities, following a months-long application and review process known as “The Wave.”
“We put out a call for two levels, or waves, of applications from our research community,” explains Dr. David Anderson, Dean of Medicine. “For Wave 1, we asked teams that see themselves as internationally competitive to come forward with proposals. For Wave 2, we were looking for proposals from teams with the potential to be internationally competitive within three to five years.”
The goal of the process was to reveal the medical school’s strongest research teams, uncover their aspirations, and identify what they need to take their work to the next level of productivity and impact.
Read more on Dal News.
- CADTH Recognizes Rising Star Dr Michelle Mujoomdar
- Dal internist co‑authors paper for The Lancet on Canada’s health leadership obligations
- Molly Appeal to support advanced brain research with new tissue processing machine
- Entering the Den for a research prize
- Dal Med Innovator | Dr. Lea Steeves
- U.S. National Institutes of Health (NIH) awards Dal‑led project $3.2 million to develop new immunotherapy drugs for advanced melanoma
- New Canada 150 Research Chair in Vaccinology and Global Health to Call Dalhousie Home
- Dalhousie Original | Dr. Ford Doolittle